BASEIMMUNE LTD
Research and experimental development on biotechnology
BASEIMMUNE LTD
Research and experimental development on biotechnology
Contact & Details
Contact
Registered Address
The London Bioscience Innovation Centre Royal College Street London NW1 0NH England
Full company profile for BASEIMMUNE LTD (12289125), an active life sciences and medical technology company based in London, England. Incorporated 30 Oct 2019. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.
Business Summary
This company specializes in providing innovative solutions and services across multiple sectors. Sign up to viewReports
Credit Report
In-depth credit score, financial analysis, risk assessment and company intelligence.
Financials
Financials
Net Assets, Total Assets & Total Liabilities (2020–2024)
Cash in Bank
£8.66M
Net Assets
£9.62M
Total Liabilities
£65.68k
Turnover
N/A
Employees
17
Debt Ratio
1%
Financial History
Revenue, profit, EBITDA and key financial figures
2024 31 Oct Year End | 2023 31 Oct Year End | |
|---|---|---|
| P&L | ||
| Revenue | ||
| Gross Profit | ||
| Operating Profit | ||
| Net Profit | ||
| EBITDA | ||
| Assets | ||
| Cash | ||
| Total Assets | ||
| Liabilities | ||
| Total Liabilities | ||
| Key Metrics | ||
| Employees | ||
Funding
Fundraising & Grants
Investors (8)
| Investor Name | Investor Since | Participating Rounds |
|---|---|---|
| Investor 2 | Apr 2021 | Series A, Seed |
| Investor 4 | Apr 2021 | Series A, Seed |
| Investor 8 | Apr 2021 | Seed |
See all 8 investors
Sign up to view complete investor information
Officers
Officers
| Status | |||||
|---|---|---|---|---|---|
| Ariane Karla Cruz Gomes | Director | Brazilian | England | 30 Oct 2019 | Active |
| Philip James Gordon Kemlo | Director | British | England | 30 Oct 2019 | Active |
See all 8 officers
Sign up to view the full officer history
Persons with Significant Control
Persons with Significant Control (3)
Ariane Karla Cruz Gomes
Brazilian
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors
Philip James Gordon Kemlo
British
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors
Joshua Miles Blight
British
- Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent,right To Appoint And Remove Directors
Group Structure
Group Structure
No group structure identified
Charges
Charges
No charges registered
Properties
Properties
No related properties
Documents
Company Filings
| Date | Category | Description | Document |
|---|---|---|---|
| 12 Nov 2025 | Officers | Change to director Ms Philip James Gordon Kemlo on 23 Sept 2025 | |
| 12 Nov 2025 | Confirmation Statement | Confirmation statement made on 29 Oct 2025 with updates | |
| 12 Nov 2025 | Officers | Change to director Dr Joshua Miles Blight on 23 Sept 2025 | |
| 12 Nov 2025 | Officers | Appointment of Kevin John Davlin Walton as director on 23 Sept 2025 | |
| 7 Nov 2025 | Capital | Capital Return Purchase Own Shares |
Change to director Ms Philip James Gordon Kemlo on 23 Sept 2025
Confirmation statement made on 29 Oct 2025 with updates
Change to director Dr Joshua Miles Blight on 23 Sept 2025
Appointment of Kevin John Davlin Walton as director on 23 Sept 2025
Capital Return Purchase Own Shares
Recent Activity
Latest Activity
Change to director Ms Philip James Gordon Kemlo on 23 Sept 2025
6 months ago on 12 Nov 2025
Confirmation statement made on 29 Oct 2025 with updates
6 months ago on 12 Nov 2025
Change to director Dr Joshua Miles Blight on 23 Sept 2025
6 months ago on 12 Nov 2025
Appointment of Kevin John Davlin Walton as director on 23 Sept 2025
6 months ago on 12 Nov 2025
Capital Return Purchase Own Shares
7 months ago on 7 Nov 2025